Literature DB >> 10591726

When can a risk factor be used as a worthwhile screening test?

N J Wald1, A K Hackshaw, C D Frost.   

Abstract

Mesh：

Year:  1999        PMID： 10591726      PMCID： PMC1117271          DOI： 10.1136/bmj.319.7224.1562

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  2 in total

1.  Apolipoproteins and ischaemic heart disease: implications for screening.

Authors:  N J Wald; M Law; H C Watt; T Wu; A Bailey; A M Johnson; W Y Craig; T B Ledue; J E Haddow
Journal:  Lancet       Date:  1994-01-08       Impact factor: 79.321

2.  Maternal serum screening for Down's syndrome: the effect of routine ultrasound scan determination of gestational age and adjustment for maternal weight.

Authors:  N J Wald; H S Cuckle; J W Densem; A Kennard; D Smith
Journal:  Br J Obstet Gynaecol       Date:  1992-02
  2 in total
  96 in total

1.  The privatization of risk.

Authors:  B Rockhill
Journal:  Am J Public Health       Date:  2001-03       Impact factor: 9.308

2.  Appraising organised screening programmes for testing for genetic susceptibility to cancer.

Authors:  V Goel
Journal:  BMJ       Date:  2001-05-12

Review 3.  Risk factor thresholds: their existence under scrutiny.

Authors:  M R Law; N J Wald
Journal:  BMJ       Date:  2002-06-29

4.  The prediction of disease risk in genomic medicine.

Authors:  Wayne D Hall; Katherine I Morley; Jayne C Lucke
Journal:  EMBO Rep       Date:  2004-10       Impact factor: 8.807

5.  Research priorities in biomarkers and surrogate end-points.

Authors:  Jeffrey K Aronson
Journal:  Br J Clin Pharmacol       Date:  2012-06       Impact factor: 4.335

6.  Evaluation of a breast cancer risk prediction model expanded to include category of prior benign breast disease lesion.

Authors:  Rulla M Tamimi; Bernard Rosner; Graham A Colditz
Journal:  Cancer       Date:  2010-11-01       Impact factor: 6.860

7.  Risk of Unplanned Emergency Department Readmission after an Acute-Care Hospital Discharge among Geriatric Inpatients: Results from the Geriatric EDEN Cohort Study.

Authors:  C P Launay; L de Decker; A Kabeshova; C Annweiler; O Beauchet
Journal:  J Nutr Health Aging       Date:  2016-02       Impact factor: 4.075

Review 8.  Measures of physical and cognitive function and work status among individuals with multiple sclerosis: a review of the literature.

Authors:  Lisa A Pompeii; Samuel D Moon; Douglas C McCrory
Journal:  J Occup Rehabil       Date:  2005-03

9.  Contributions of 18 additional DNA sequence variations in the gene encoding apolipoprotein E to explaining variation in quantitative measures of lipid metabolism.

Authors:  Jari H Stengård; Andrew G Clark; Kenneth M Weiss; Sharon Kardia; Deborah A Nickerson; Veikko Salomaa; Christian Ehnholm; Eric Boerwinkle; Charles F Sing
Journal:  Am J Hum Genet       Date:  2002-08-05       Impact factor: 11.025

Review 10.  Circulating insulin-like growth factor peptides and prostate cancer risk: a systematic review and meta-analysis.

Authors:  Mari-Anne Rowlands; David Gunnell; Ross Harris; Lars J Vatten; Jeff M P Holly; Richard M Martin
Journal:  Int J Cancer       Date:  2009-05-15       Impact factor: 7.396
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.